Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy for UTUC with LVI
NCT04255771Phase 3Unknown
- Start
- Mar 2020
- Primary completion
- Mar 2023
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, Cisplatin micelle injection (HA132) in upper urinary tract urothelial carcinoma (UTUC). Status: unknown.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)
03
Conditions
upper urinary tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT04255771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04255771.